PRESS RELEASE published on 12/10/2025 at 00:00, 6 months 26 days ago Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care Onco-Innovations completes fourth session of Colorectal Cancer Canada's Catalysts Series focused on precision oncology and data-driven innovation, with key industry leaders participating in discussions on advancing national progress Precision Oncology Onco-Innovations Colorectal Cancer Canada Data-driven Innovation National Progress
BRIEF published on 12/07/2025 at 09:05, 6 months 29 days ago Onco-Innovations Plans Nasdaq Cross-listing and Possible Equity Offering Equity Financing Cancer Research Investment Bank Onco-Innovations Nasdaq Cross-listing
BRIEF published on 12/07/2025 at 09:05, 6 months 29 days ago Onco-Innovations prévoit une cotation croisée au Nasdaq et une possible offre d'actions. Financement Par Actions Banque D'investissement Recherche Sur Le Cancer Onco-Innovations Cotation Croisée Au Nasdaq
PRESS RELEASE published on 12/07/2025 at 09:00, 6 months 29 days ago Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering Onco-Innovations engages U.S. investment bank for potential Nasdaq cross-listing and equity financing, part of long-term corporate development strategy Equity Financing Nasdaq Investment Bank Onco-Innovations Cross-listing
BRIEF published on 11/25/2025 at 22:35, 7 months 9 days ago Onco-Innovations Engages in University of Alberta's Innovation Awards Cancer Research Innovation Awards Onco-Innovations PNKP Technology University Of Alberta
BRIEF published on 11/25/2025 at 22:35, 7 months 9 days ago Onco-Innovations participe aux prix d'innovation de l'Université de l'Alberta Prix De L'innovation Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Université De L'Alberta
PRESS RELEASE published on 11/25/2025 at 22:30, 7 months 9 days ago Onco-Innovations Attends University of Alberta's 2025 Innovation Awards Onco-Innovations recognized at University of Alberta's 2025 Innovation Awards for advancing oncology innovation and commercializing PNKP Inhibitor Technology from university research Innovation Awards Cancer Therapeutics Onco-Innovations University Of Alberta PNKP Inhibitor Technology
BRIEF published on 11/21/2025 at 01:35, 7 months 14 days ago Onco-Innovations accélère la production d'inhibiteurs de PNKP grâce à un partenariat avec Dalton. Traitement Du Cancer Études Cliniques Optimisation De La Production Services Pharmaceutiques Dalton Inhibiteur De PNKP
BRIEF published on 11/21/2025 at 01:35, 7 months 14 days ago Onco-Innovations Advances PNKP Inhibitor Scale-Up with Dalton Partnership Cancer Treatment Clinical Studies Dalton Pharma Services PNKP Inhibitor Manufacturing Optimization
PRESS RELEASE published on 11/21/2025 at 01:30, 7 months 14 days ago Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies Onco-Innovations partners with Dalton Pharma Services for A83B4C63 manufacturing optimization and scale-up activities, aiming for future clinical material production Onco-Innovations Dalton Pharma Services Manufacturing Optimization Scale-up Activities Clinical Material Production
Published on 07/03/2026 at 23:00, 1 day 23 hours ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 2 days ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 2 days 2 hours ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 2 days 8 hours ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/05/2026 at 13:45, 8 hours 34 minutes ago XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 8 hours 34 minutes ago XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 1 day 4 hours ago Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 1 day 11 hours ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day 13 hours ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 21:49, 2 days ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 2 days ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 2 days 3 hours ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 2 days 3 hours ago Disclosure of transactions in own shares from July 1 to July 3, 2026